These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 468981)

  • 1. Effect of flutamide on estradiol metabolism.
    Zumoff B; Fishman J; Freed S; Levin J; Whitmore WF; Hellman L; Fukushima DK
    J Clin Endocrinol Metab; 1979 Sep; 49(3):467-8. PubMed ID: 468981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of flutamide on testosterone metabolism and the plasma levels of androgens and gonadotropins.
    Hellman L; Bradlow HL; Freed S; Levin J; Rosenfeld RS; Whitmore WF; Zumoff B
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1224-9. PubMed ID: 591617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flutamide on cortisol metabolism.
    Fukushima DK; Levin J; Kream J; Freed SZ; Whitmore WF; Hellman L; Zumoff B
    J Clin Endocrinol Metab; 1978 Oct; 47(4):788-91. PubMed ID: 263325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroid antiandrogen inhibiting effect on testosterone metabolism in rat prostate and liver.
    Reznikov A; Korpacheva T
    Endocrinol Exp; 1990 Dec; 24(4):437-47. PubMed ID: 2096078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
    Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
    Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide. Mechanism of action of a new nonsteroidal antiandrogen.
    Sufrin G; Coffey DS
    Invest Urol; 1976 May; 13(6):429-34. PubMed ID: 1270239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L
    Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer.
    Brogden RN; Clissold SP
    Drugs; 1989 Aug; 38(2):185-203. PubMed ID: 2670515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the effects of flutamide on cortisol metabolism.
    Fukushima DK; Smulowitz M; Levin J
    Steroids; 1980 Feb; 35(2):209-17. PubMed ID: 7376219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R; Lachance R; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.
    Moorjani S; Dupont A; Labrie F; Lupien PJ; Gagné C; Brun D; Giguère M; Bélanger A; Cusan L
    J Clin Endocrinol Metab; 1988 Feb; 66(2):314-22. PubMed ID: 3276721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
    Crawford ED; Eisenberger MA; McLeod DG; Spaulding JT; Benson R; Dorr FA; Blumenstein BA; Davis MA; Goodman PJ
    N Engl J Med; 1989 Aug; 321(7):419-24. PubMed ID: 2503724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade.
    Schellhammer PF; Venner P; Haas GP; Small EJ; Nieh PT; Seabaugh DR; Patterson AL; Klein E; Wajsman Z; Furr B; Chen Y; Kolvenbag GJ
    J Urol; 1997 May; 157(5):1731-5. PubMed ID: 9112515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salutary clinical response of prostate cancer to antiandrogen withdrawal: assessment of flutamide in an in vitro paradigm predictive of tumor growth enhancement.
    Brandes LJ; Queen GM; LaBella FS
    Clin Cancer Res; 1997 Aug; 3(8):1357-61. PubMed ID: 9815819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.
    Kontula KK; Seppänen PJ; van Duyne P; Bardin CW; Jänne OA
    Endocrinology; 1985 Jan; 116(1):226-33. PubMed ID: 3964747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
    Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.
    Knuth UA; Hano R; Nieschlag E
    J Clin Endocrinol Metab; 1984 Nov; 59(5):963-9. PubMed ID: 6237116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
    Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.